Target of rapamycin inhibitors (TOR‐I) vs calcineurin inhibitors (CNI): main outcomes
Biopsy‐proven acute rejection · primary immunosuppression in kidney transplant recipients
Target of rapamycin inhibitors (TOR‐I) probably leads to higher biopsy‐proven acute rejection compared with calcineurin inhibitors (CNI): main outcomes (moderate certainty).
1 finding from 1 review
- Target of rapamycin inhibitors (TOR‐I; sirolimus and everolimus) for primary immunosuppression in kidney transplant… 2019 · Cochrane Headline outcomes onlyRR 1.7 [1.32, 2.19]15 studies · 3309 participantsModerate